secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRIDEX CORP (IRIX)
CIK:        0001006045
Form:       8-K
Filed at:   2022-03-21T23:59:59+00:00
Accession:  0001564590-22-011195
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iridex appoints Beverly Huss to board, expanding from five to six members
-------------------------------------------------------------------------

- Appointment effective March 17, 2022; board size increased from 5 to 6.
- Ms. Huss received a nonstatutory stock option for 15,000 shares vesting monthly over 4 years.
- She brings over 25 years of medical device management and board experience.
- Currently CEO of Pagonia Medical; former CEO of Qool Therapeutics and Guidant executive.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006045/000156459022011195/0001564590-22-011195-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006045/000156459022011195/irix-8k_20220321.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-011195

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer